 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TRACON Pharmaceuticals, Inc. engages in the development and commercialization of targeted therapies for cancer, and ophthalmic and fibrotic diseases. Its products include TRC105, an anti-endoglin antibody for the treatment of solid tumor types, TRC205 created for the treatment of fibrotic diseases, and TRC102, a small molecule that is in clinical development made for lung cancer and glioblastoma. The company was founded in October 2004 and is headquartered in San Diego, CA.

Current Price	$0.64
Prev Close	$0.63
Open	$0.64
Dividend Yield	0.00%
50-Day Moving Average	$1.14
Beta	1.05
Avg. Volume	95,397.18
PE Ratio	-0.49

52-Week High	$2.32
52-Week Low	$0.55
Market Capitalization	$15.59M
EPS	-$1.28
Price to Book	-1.37
Revenue Per Employee	N/A
Enterprise Value/EBITDA	-1.48

TCON TRACON Pharmaceuticals Inc

About

Feed

Fundamentals

News